Loading clinical trials...
Loading clinical trials...
The aging population in Europe is leading to an increase in neurodegenerative diseases, such as Alzheimer's disease (AD), which is expected to affect 152 million people worldwide by 2050. In Italy, th...
Keep your clinical trial research organized — questions to ask, what to expect, and key details.
Lead Sponsor
IRCCS San Raffaele
NCT05592678 · Alzheimer's Disease (AD), Dementia, and more
NCT07101380 · Mild Cognitive Impairment (MCI)
NCT06669546 · Cognitive Decline, Alzheimer Disease, and more
NCT03653156 · Mild Cognitive Impairment(MCI), Alzheimer Disease, Late Onset, and more
NCT06780917 · Mild Cognitive Impairment (MCI), Major Depressive Disorder, Remitted, and more
IRCCS San Raffele
Milan, Italy
Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.
Start free trial →Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions